Multimodality molecular imaging of apoptosis in oncology

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages 308-317

  Blankenberg, Francis G ^a   Norfray, Joseph F ^b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b Chicago Northside MRI Center   (United States)

Author keywords

Annexin V; Apoptosis; Caspase; Choline; Lipids; MR spectroscopy; Phosphatidylserine

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ADENOSINE DIPHOSPHATE RIBOSE; APOPTOSOME; CARMUSTINE; CASPASE 3; CASPASE 7; CHOLINE; CISPLATIN; DOXORUBICIN; FAS LIGAND; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GEFITINIB; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GUANINE NUCLEOTIDE EXCHANGE FACTOR; IMATINIB; INITIATION FACTOR 2; IODINE 124; ISATIN DERIVATIVE; LIPOCORTIN 5; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; TECHNETIUM 99M; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; AUTOPHAGY; CELL DEATH; CHELATION; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DNA DAMAGE; DRUG RESPONSE; ECHOGRAPHY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVITY; GASTROINTESTINAL STROMAL TUMOR; HODGKIN DISEASE; HUMAN; HYDROGEN BOND; INFRARED SPECTROSCOPY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR IMAGING; NONHUMAN; OLIGOMERIZATION; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCINTISCANNING; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CASPASES; CHOLINE; HUMANS; INFRARED RAYS; MOLECULAR IMAGING; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; RADIOPHARMACEUTICALS; SIGNAL TRANSDUCTION;

EID: 79960740113     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.6953     Document Type: Review

References (107)

1. Ameisen JC. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ 2002; 9:367-393 (Pubitemid 34822817)
2. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005; 73:1907-1916 (Pubitemid 40470787)
3. Chan A, Reiter R, Wiese S, Fertig G, Gold R. Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models. Histochem Cell Biol 1998; 110:553-558 (Pubitemid 28535610)
4. Martin SJ, Reutelingsperger CP, McGahon AJ. Early redistribution of plasma membrane phosphatidylserine in a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182:1545-1556
5. Huerta S, Goulet EJ, Huerta-Yepez S, Livingston EH. Screening and detection of apoptosis. J Surg Res 2007; 139:143-156 (Pubitemid 46482558)
6. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 2000; 97:14376-14381 (Pubitemid 32016583)
7. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89:1121-1132 (Pubitemid 27079974)
8. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62:971-988 (Pubitemid 40655614)
9. Wood BL, Gibson DF, Tait JF. Increased phosphatidylserine exposure in sickle cell disease: flow cytometric measurement and clinical associations. Blood 1996; 88:1873-1880 (Pubitemid 26307087)
10. Egger L, Madden DT, Rheme C, Rao RV, Bredesen DE. Endoplasmic reticulum stress-induced cell death mediated by the proteasome. Cell Death Differ 2007; 14:1172-1180 (Pubitemid 46785108)
11. Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastasis Rev 2008; 27:471-480
12. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42
13. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8:741-752 (Pubitemid 47312826)
14. Aguilar-Quesada R, Muñoz-Gámez JA, Martín-Oliva D, et al. Modulation of Transcription by PARP-1: consequences in carcinogenesis and inflammation. Curr Med Chem 2007; 14:1179-1187
15. Boersma HH, Kietselaer BL, Stolk LM, et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 2005; 46:2035-2050 (Pubitemid 46657451)
16. Lahorte CM, Vanderheyden JL, Steinmetz N, Van de Wiele C, Dierckx RA, Slegers G. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging 2004; 31:887-919 (Pubitemid 38765126)
17. Munoz LE, Frey B, Pausch F, et al. The role of annexin A5 in the modulation of the immune response against dying and dead cells. Curr Med Chem 2007:14:271-277
18. Boersma HH, Liem IH, Kemerink GJ, et al. Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. Br J Radiol 2003; 76:553-560 (Pubitemid 37028410)
19. Belhocine T, Steinmetz N, Hustinx R, et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 2002; 8:2766-2774 (Pubitemid 35025718)
20. Blankenberg F. To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. Clin Cancer Res 2002; 8:2757-2758 (Pubitemid 35025716)
21. 99mTc-HYNIC-annexin V: a novel human recombinant annexin V for human application. J Nucl Med 2003; 44:947-952
22. Van den Brande JM, Koehler TC, Zelinkova Z, et al. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease. Gut 2007; 56:509-517 (Pubitemid 46580507)
23. Haas RL, de Jong D, Valdes Olmos RA, et al. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys 2004; 59:782-787 (Pubitemid 38748743)
24. 99mTc-HYNIC annexin-V imaging in head and neck carcinoma. Cancer Biother Radiopharm 2004; 19:205-210
25. 99mTc-annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 2004; 72:333-339
26. 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med 2006; 47:1813-1818
27. 99mTc HYNIC-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol 2007; 25:2534-2539
28. 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome. Nucl Med Commun 2008; 29:39-44
29. Rottey S, Van den Bossche B, Slegers G, Van Belle S, van de Wiele C. Influence of chemotherapy on the biodistribution of [(99m)Tc] hydrazinonicotinamide annexin V in cancer patients. Q J Nucl Med Mol Imaging 2009; 53:127-132
30. Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW. Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. Bioconjug Chem 2000; 11:918-925
31. Jin M, Smith C, Hsieh HY, Gibson DF, Tait JF. Essential role of B-helix calcium binding sites in annexin V-membrane binding. J Biol Chem 2004; 279:40351-40357 (Pubitemid 39287621)
32. 99mTc-annexin V. J Nucl Med 2005; 46:807-815
33. Tait JF, Smith C, Levashova Z, Patel B, Blankenberg FG, Vanderheyden JL. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods. J Nucl Med 2006; 47:1546-1553
34. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 2004; 31:469-474
35. Li X, Link JM, Stekhova S, et al. Site-specific labeling of annexin V with F-18 for apoptosis imaging. Bioconjug Chem 2008; 19:1684-1688
36. 18F-FDG, and histologic evaluation. J Nucl Med 2005; 46:794-799
37. 18F-FDG PET/CT and apoptosis induced by neoadjuvant chemotherapy in breast cancer. Cancer Biol Ther 2007; 6:1442-1448
38. 18F]-2-Fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil. Br J Cancer 2007; 97:902-909
39. Trent JC, Ramdas L, Dupart J, et al. Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor. Cancer 2006; 107:1898-1908 (Pubitemid 44582961)
40. Su H, Bodenstein C, Dumont RA, et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 2006; 12:5659-5667 (Pubitemid 44629592)
41. Haberkorn U, Bellemann ME, Brix G, et al. Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine. Eur J Nucl Med 2001; 28:418-425 (Pubitemid 32260907)
42. Mortimer JE, Dehdashti F, Siegel BA, et al. Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol 2001; 19:2797-2803 (Pubitemid 32538187)
43. Thapa N, Kim S, So IS, et al. Discovery of a phosphatidylserine- recognizing peptide and its utility in molecular imaging of tumour apoptosis. J Cell Mol Med 2008; 12(5A):1649-1660
44. 99mTc-labeled C2A domain of synaptotagmin I as a target specific molecular probe for noninvasive imaging of acute myocardial infarction. J Nucl Med 2006; 47:1367-1374
45. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 2001; 7:1241-1244 (Pubitemid 33063780)
46. Jung HI, Kettunen MI, Davletov B, Brindle KM. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug Chem 2004; 15:983-987 (Pubitemid 39297818)
47. Krishnan AS, Neves AA, de Backer MM, et al. Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent. Radiology 2008; 246:854-862
48. Alam IS, Neves AA, Witney TH, Boren J, Brindle KM. Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death. Bioconjug Chem 2010; 21:884-891
49. Hanshaw RG, Lakshmi C, Lambert TN, Johnson JR, Smith BD. Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine. Chembiochem 2005; 6:2214-2220
50. Bose S, Tuunainen I, Parry M, Medina OP, Mancini G, Kinnunen PK. Binding of cationic liposomes to apoptotic cells. Anal Biochem 2004; 331:385-394
51. Shao R, Xiong C, Wen X, Gelovani JG, Li C. Targeting phosphatidylserine on apoptotic cells with phages and peptides selected from a bacteriophage display library. Mol Imaging 2007; 6:417-426
52. Thapa N, Kim S, So IS, Lee BH, Kwon IC, Choi K, Kim IS. Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis. J Cell Mol Med 2008; 12:1649-1660
53. Wang K, Purushotham S, Lee JY, et al. In vivo imaging of tumor apoptosis using histone H1-targeting peptide. J Control Release 2010; 148:283-291
54. 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Bioorg Med Chem Lett 2006; 16:5041-5046
55. 18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q J Nucl Med Mol Imaging 2007; 51:67-73
56. Rosado JA, Lopez JJ, Gomez-Arteta E, Redondo PC, Slaido GM, Pariente JA. Early caspase-3 activation independent of apoptosis is required for cellular function. J Cell Physiol 2006; 209:142-152 (Pubitemid 44318675)
57. Spires-Jones TL, de Calignon A, Matsui T, et al. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J Neurosci 2008; 28:862-867 (Pubitemid 351158993)
58. 18F] fluoroethylazide. J Med Chem 2008; 51:8057-8067
59. 18F]-labeled isatin sulfonamide. Proc Natl Acad Sci USA 2009; 106:16375-16380
60. Chen DL, Zhou D, Chu W, et al. Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography. Nucl Med Biol 2009; 36:651-658
61. 11C]WC-98. Org Biomol Chem 2009; 7:1337-1348
62. Reshef A, Shirvan A, Grimberg H, et al. Novel molecular imaging of cell death in experimental cerebral stroke. Brain Res 2007; 1144:156-164 (Pubitemid 46440847)
63. Damianovich M, Ziv I, Heyman SN, et al. Apo-Sense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging 2006; 33:281-291
64. Aloya R, Shirvan A, Grimberg H, et al. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis 2006; 11:2089-2101 (Pubitemid 44885386)
65. Cohen A, Ziv I, Aloya T, et al. monitoring of chemotherapy-induced cell death in melanoma tumors by N,N′-didansyl-L-cystine. Technol Cancer Res Treat 2007; 6:221-233 (Pubitemid 47021073)
66. Grimberg H, Levin G, Shirvan A, et al. Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis 2009; 14:257-267
67. Cheng C, Xue W, Diao H, et al. Antitumor activity and toxicological properties of doxorubicin conjugated to α,β-poly[(2-hydroxyethyl)-L- aspartamide] administered intraperitoneally in mice. Anticancer Drugs 2010; 21:362-371
68. Meer L, Schold SC, Kleihues P. Inhibition of the hepatic O6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochem Pharmacol 1989; 38:929-934 (Pubitemid 19074664)
69. 31P nuclear magnetic resonance spectroscopy of rat 9L gliosarcoma treated with BCNU: dose response of spectral changes. Magn Reson Med 1989; 11:258-266
70. Weinberg MJ, Rauth AM. 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1987; 13:1691-1699 (Pubitemid 17160133)
71. Blankenberg FG, Storrs RW, Naumovski L, Goralski T, Spielman D. Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood 1996; 87:1951-1956 (Pubitemid 26068910)
72. Blankenberg FG, Katsikis PD, Storrs RW, et al. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997; 89:3778-3786 (Pubitemid 27227102)
73. Engelmann J, Henke J, Willker W, et al. Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy. Anticancer Res 1996; 16:1429-1439 (Pubitemid 26257812)
74. 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998; 58:3791-3799
75. 1H NMR detection of mobile lipids as a marker for apoptosis: the case of anticancer drug-loaded liposomes and polymeric micelles. Mol Pharm 2009; 6:1867-1882
76. Lindskog M. Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations. Cancer Lett 2005; 228:247-255 (Pubitemid 41188448)
77. Clemens MJ, Bushel M, Jeffrey IW, Pain VM, Morley SJ. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 2000; 7:603-615 (Pubitemid 30456166)
78. Morley SJ, Coldwell MJ, Clemens MJ. Initiation factor modifications in the preapoptotic phase. Cell Death Differ 2005; 12:571-584 (Pubitemid 40774768)
79. Alexander A, Murtha A, Abdulkarim B, et al. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma. Clin Invest Med 2006; 29:301-311 (Pubitemid 44870742)
80. Chen CY, Li CW, Kuo YT, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants - initial experience. Radiology 2006; 239:448-456
81. Hsieh TJ, Li CW, Chuang HY, Liu GC, Wang CK. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. J Comput Assist Tomogr 2008; 32:987-994
82. 18F]-fluorodeoxyglucose positron emission tomography. J Magn Reson Imaging 2008; 28:420-427
83. 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. Jpn J Radiol 2010; 28:101-109
84. 1H MR spectroscopy using the external standard method. J Magn Reson Imaging 2010; 31:895-902
85. 1H MRS. NMR Biomed 2010; 23:56-65
86. 1H magnetic resonance spectroscopy and imaging. NMR Biomed 2010; 23:624-632
87. Huuse EM, Jensen LR, Goa PE, et al. Monitoring the effect of docetaxel treatment in MCF7 xenografts using multimodal in vivo and ex vivo magnetic resonance methods, histopathology, and gene expression. Transl Oncol 2010; 3:252-263
88. 1H MRS during gene therapy-induced apoptosis: interrelationships between water diffusion and mobile lipids. NMR Biomed 2009; 22:272-279
89. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. NMR Biomed 2004; 17:1-9
90. Lyng H, Sitter B, Bathen TF, et al. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas. BMC Cancer 2007; 7:11
91. Lidar Z, Mardor Y, Jonas T, et al. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 2004; 100:472-479 (Pubitemid 38269075)
92. Valonen PK, Lehtimäki KK, Väisänen TH, et al. Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density. J Magn Reson Imaging 2004; 19:389-396 (Pubitemid 38437145)
93. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006; 6:135-143
94. Deng J, Miller FH, Rhee TK, et al. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 2006; 17:1195-1200 (Pubitemid 44318703)
95. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11:102-125
96. Rozel S, Galbán CJ, Nicolay K, et al. Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J Cell Biochem 2009; 107:58-64
97. Huang MQ, Pickup S, Nelson DS, et al. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T2-weighted and diffusion-weighted MRI. NMR Biomed 2008; 21:1021-1029
98. Kim H, Morgan DE, Zeng H, et al. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology 2008; 248:844-851
99. Lansberg MG, Thijs VN, O'Brien MW, et al. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. AJNR 2001; 22:637-644 (Pubitemid 32318688)
100. Czarnota GJ, Kolios MC, Abraham J, et al. Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo. Br J Cancer 1999; 81:520-527 (Pubitemid 29458808)
101. Banihashemi B, Vlad R, Debeljevic B, Giles A, Kolios MC, Czarnota GJ. Ultrasound imaging of apoptosis in tumor response: novel preclinical monitoring of photodynamic therapy effects. Cancer Res 2008; 68:8590-8596
102. Vlad RM, Alajez NM, Giles A, Kolios MC, Czarnota GJ. Quantitative ultrasound characterization of cancer radiotherapy effects in vitro. Int J Radiat Oncol Biol Phys 2008; 72:1236-1243
103. Farhat G, Yang VX, Czarnota GJ, Kolios MC. Detecting cell death with optical coherence tomography and envelope statistics. J Biomed Opt 2011; 16:026017
104. Strohm E, Czarnota GJ, Kolios MC. Quantitative measurements of apoptotic cell properties using acoustic microscopy. IEEE Trans Ultrason Ferroelectr Freq Control 2010; 57:2293-2304
105. Holman HY, Martin MC, Blakely EA, Bjornstad K, McKinney WR. IR spectroscopic characteristics of cell cycle and cell death probed by synchrotron radiation based Fourier transform IR spectromicroscopy. Biopolymers 2000; 57:329-335
106. Holman HY, Bechtel HA, Hao Z, Martin MC. Synchrotron IR spectromicroscopy: chemistry of living cells. Anal Chem 2010 Sep 14 [Epub ahead of print]
107. Holman HY, Bjornstad KA, Martin MC, McKinney WR, Blakely EA, Blankenberg FG. Mid-infrared reflectivity of experimental atheromas. J Biomed Opt 2008; 13:030503